Mitsubishi UFJ Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,602
| Closed | -$104K | – | 1126 |
|
|
2023
Q1 | $104K | Buy |
10,602
+769
| +8% | +$7.57K | ﹤0.01% | 1088 |
|
|
2022
Q4 | $179K | Sell |
9,833
-838
| -8% | -$15.3K | ﹤0.01% | 1032 |
|
|
2022
Q3 | $221K | Buy |
10,671
+129
| +1% | +$2.67K | ﹤0.01% | 1012 |
|
|
2022
Q2 | $219K | Buy |
10,542
+6,805
| +182% | +$141K | ﹤0.01% | 1034 |
|
|
2022
Q1 | $161K | Buy |
3,737
+408
| +12% | +$17.6K | ﹤0.01% | 1084 |
|
|
2021
Q4 | $208K | Sell |
3,329
-427
| -11% | -$26.7K | ﹤0.01% | 1077 |
|
|
2021
Q3 | $323K | Hold |
3,756
| – | – | ﹤0.01% | 1003 |
|
|
2021
Q2 | $418K | Buy |
3,756
+1,083
| +41% | +$121K | ﹤0.01% | 980 |
|
|
2021
Q1 | $298K | Buy |
2,673
+846
| +46% | +$94.3K | ﹤0.01% | 954 |
|
|
2020
Q4 | $194K | Buy |
1,827
+719
| +65% | +$76.3K | ﹤0.01% | 956 |
|
|
2020
Q3 | $154K | Buy |
1,108
+12
| +1% | +$1.67K | ﹤0.01% | 923 |
|
|
2020
Q2 | $355K | Buy |
+1,096
| New | +$355K | ﹤0.01% | 802 |
|
|
2019
Q4 | – | Sell |
-3,373
| Closed | -$83K | – | 1024 |
|
|
2019
Q3 | $83K | Buy |
3,373
+440
| +15% | +$10.8K | ﹤0.01% | 921 |
|
|
2019
Q2 | $103K | Buy |
2,933
+307
| +12% | +$10.8K | ﹤0.01% | 912 |
|
|
2019
Q1 | $118K | Buy |
2,626
+223
| +9% | +$10K | ﹤0.01% | 863 |
|
|
2018
Q4 | $123K | Buy |
2,403
+186
| +8% | +$9.52K | ﹤0.01% | 817 |
|
|
2018
Q3 | $148K | Buy |
+2,217
| New | +$148K | ﹤0.01% | 807 |
|